Clinical Trial Update: Bioequivalence Study of Clopidogrel Tablets 75 mg of Dr. Reddy's Under Fasting Conditions [Phase 1]

View source ↗

Summary

This document reports the completion of a Phase 1 bioequivalence study evaluating Dr. Reddy's 75 mg clopidogrel tablets under fasting conditions. The trial is d…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome
• Myocardial Infarction
• Peripheral Artery Disease
• Stroke

Drugs mentioned

• CLOPIDOGREL (CLOPIDOGREL)

Snippet

Sponsor: Dr. Reddy's Laboratories Limited | Conditions: Fasting | Phase 1 | Status: COMPLETED